ZA889256B - New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters - Google Patents

New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters

Info

Publication number
ZA889256B
ZA889256B ZA889256A ZA889256A ZA889256B ZA 889256 B ZA889256 B ZA 889256B ZA 889256 A ZA889256 A ZA 889256A ZA 889256 A ZA889256 A ZA 889256A ZA 889256 B ZA889256 B ZA 889256B
Authority
ZA
South Africa
Prior art keywords
transterase
comt
catechol
inhibitors
esters
Prior art date
Application number
ZA889256A
Inventor
Paeivi Aho
Aho Paeivi
Pentti Pohto
Pohto Pentti
Inge-Britt Linden
Linden Inge-Britt
Reijo Baeckstroem
Baeckstroem Reijo
Erkki Honkanen
Honkanen Erkki
Erkki Nissinen
Nissinen Erkki
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA889256B publication Critical patent/ZA889256B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
ZA889256A 1987-12-24 1988-12-09 New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters ZA889256B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730190A GB8730190D0 (en) 1987-12-24 1987-12-24 New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters

Publications (1)

Publication Number Publication Date
ZA889256B true ZA889256B (en) 1989-08-30

Family

ID=10629088

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889256A ZA889256B (en) 1987-12-24 1988-12-09 New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters

Country Status (4)

Country Link
KR (1) KR890009384A (en)
GB (2) GB8730190D0 (en)
UA (1) UA15922A1 (en)
ZA (1) ZA889256B (en)

Also Published As

Publication number Publication date
GB8730190D0 (en) 1988-02-03
GB8820729D0 (en) 1988-10-05
KR890009384A (en) 1989-08-01
UA15922A1 (en) 1997-06-30

Similar Documents

Publication Publication Date Title
EP0532466A3 (en) Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
NZ224361A (en) Preparation of (6s)-folinic acid and its salts
PH27400A (en) New therapeutically active compound and method of use thereof
EP0295721A3 (en) Promotion of healing of meniscal tissue
IL113433A0 (en) Tablet formulations comprising amoxycillin and salts of clavulanic acid
EP0526630A4 (en) Use of gm-csf and g-csf to promote accelerated wound healing
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
HK26696A (en) Preparation of clavulanic acid and its salts and esters
JPS6447799A (en) Tissue factor inhibitor
ZA891402B (en) 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion
HU893412D0 (en) Inhibitors of interleucin-1
EP0323162A3 (en) New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
ZA883744B (en) Promotion of healing of meniscal tissue
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
PH25869A (en) Catechol carboxylic acid derivatives and compositions thereof
ZA889256B (en) New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters
IL95484A0 (en) Iodopropargyl esters of alpha-amino acid derivatives and their use as antimicrobial agents
EP0404834A4 (en) Squalene oxide cyclase inhibitors and therapeutic use thereof
NZ217724A (en) Esters of dihydrolysergic acid and pharmaceutical composition
IL88037A0 (en) Potentiation of antihypertensive effect of ace inhibitors
GB2151619B (en) Imidazoquinoline and analogues derivatives of
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
GB2220652B (en) Treatment of pastures
EP0380985A3 (en) Esters of 4-aryl-2-halogen imidazol-5-carbonic acid, their preparation and use
SG144094G (en) Oral formulation of buspirone and salts thereof